Title : PTEN activation sensitizes breast cancer to PI3-kinase inhibitor through the β-catenin signaling pathway.

Pub. Date : 2012 Sep

PMID : 22710837






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Herein, we show that AD-PTEN significantly enhanced the sensitization of breast cancer cells to LY294002. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one phosphatase and tensin homolog Homo sapiens
2 In addition, treatment of AD-PTEN-transfected cells with LY294002 resulted in significantly reduced cell viability and invasion ability compared to single LY294002 treatment. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one phosphatase and tensin homolog Homo sapiens
3 In addition, treatment of AD-PTEN-transfected cells with LY294002 resulted in significantly reduced cell viability and invasion ability compared to single LY294002 treatment. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one phosphatase and tensin homolog Homo sapiens
4 Our results indicate that AD-PTEN sensitization of breast cancer to LY294002 is achieved by increased GSK-3beta activity, thus resulting in inhibition of the beta-catenin signaling pathway. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one phosphatase and tensin homolog Homo sapiens